Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-17 Purchase(A) |
2023-03-23 4:14 pm |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
1,811,594 | $2.76 | $4,999,999 | 5,952,263 (Direct) |
View |
2023-03-17 Purchase |
2023-03-21 6:07 pm |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
1,811,594 | $2.76 | $4,999,999 | 7,032,770 (Indirect Direct) |
View |
2020-06-03 Sale |
2020-06-04 4:25 pm |
Cortexyme Inc. | CRTX | PFIZER INC Pfizer Strategic Investment Holdings LLC Pfizer Ventures (US) LLC 10% Owner |
370,000 | $40.18 | $14,866,600 | 2,879,973 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-10-13 08:34 am |
N/A N/A |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
0 | $0 | 5,221,176 (Direct) |
View |
2020-12-18 Conversion |
2020-12-22 5:58 pm |
N/A N/A |
BioAtla Inc. | BCAB | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
2,238,090 | $0 | 2,238,090 (Indirect) |
View |
Ownership |
2020-12-15 6:03 pm |
N/A N/A |
BioAtla Inc. | BCAB | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
0 | $0 | 2,238,090 (Indirect) |
View |